BioCellChallenge (BCC) is biotechnology company created in 2009. Our mission is to develop best-in-class intracellular internalization technologies allowing the design of new therapeutics. Based on the very promising results BCC obtained for transporting therapeutic antibodies directly into the cells, we plan to develop the first drug candidate based on our technology, dedicated to cancer therapy, without using any cytotoxic chemical.